Skip to Main Content

Paper Details

Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease.
Nat Neurosci
374
2014
AD, ANK1, Alzheimer's disease, ankyrin 1, ankyrin 1 (ANK1) gene, chronic neurodegenerative disorder, cognitive decline, complex disease, cortical samples, differentially methylated region, human, neurodegeneration, neuropathology, whole blood
Author NameAffiliation
Eilis HannonUniversity of Exeter Medical School, Exeter University
Philip L De JagerInstitute for the Neurosciences, Brigham and Women's Hospital, USA. [2] Harvard Medical School, Broad Institute
Philip L De JagerInstitute for the Neurosciences, Brigham and Women's Hospital, USA. [2] Harvard Medical School, Broad Institute
Gyan P SrivastavaInstitute for the Neurosciences, Brigham and Women's Hospital, Broad Institute
Safa Al-SarrajInstitute of Psychiatry, King's College London
Joe BurrageUniversity of Exeter Medical School, Exeter University
Vahram HaroutunianThe Icahn School of Medicine at Mount Sinai, USA. [3] JJ Peters Virginia Medical Center
Zachary A KaminskyJohns Hopkins University School of Medicine, Johns Hopkins Bloomberg School of Public Health
Simon Lovestone1] Institute of Psychiatry, King's College London, Warneford Hospital, University of Oxford
David A BennettRush University Medical Center
David A BennettRush University Medical Center
Leonard C Schalkwyk1] Institute of Psychiatry, King's College London
Jonathan Mill1] University of Exeter Medical School, Exeter University, UK. [2] Institute of Psychiatry, King's College London
Jonathan Mill1] University of Exeter Medical School, Exeter University, UK. [2] Institute of Psychiatry, King's College London
  • 1 - 14

Datasets